← Back to directory

Norbert Frey

Researcher Next ID · RN-032205

Researcher · Medicine

Christian-Albrechts-Universität zu Kiel

Kiel, Germany

Accepting doctoral researchersFunding unknown
Works count
1,381
Citation count
44,180
H-index
69
i10-index
357

Research interests

Medicine
Cardiac Valve Diseases and Treatments
Cardiovascular Function and Risk Factors
Cardiomyopathy and Myosin Studies
Cardiac Imaging and Diagnostics
Cardiac Fibrosis and Remodeling

Publications

  • A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation

    Signal Transduction and Targeted Therapy · 2024 · 10.1038/s41392-024-01946-6

  • Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

    New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2400685

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

  • Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial

    European Heart Journal · 2020 · 10.1093/eurheartj/ehaa036

  • Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation

    Circulation · 2020 · 10.1161/circulationaha.120.048792

  • Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants

    Nature Communications · 2020 · 10.1038/s41467-020-19230-w

  • Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

    Immunity · 2020 · https://doi.org/10.1016/j.immuni.2020.11.017

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31792-x

  • Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy

    Human Molecular Genetics · 2017 · 10.1093/hmg/ddx283

  • Heart Failure is Associated with Depletion of Core Intestinal Microbiota

    ESC Heart Failure · 2017 · 10.1002/ehf2.12155

  • Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation

    CPT Pharmacometrics & Systems Pharmacology · 2015 · 10.1002/psp4.12049

  • Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

    Cell Metabolism · 2015 · https://doi.org/10.1016/j.cmet.2015.09.002

  • RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction

    Cardiovascular Research · 2014 · 10.1093/cvr/cvu146

  • Mechanisms of disease: hypertrophic cardiomyopathy

    Nature Reviews Cardiology · 2011 · 10.1038/nrcardio.2011.159

  • The sarcomeric Z-disc: a nodal point in signalling and disease

    Journal of Molecular Medicine · 2006 · 10.1007/s00109-005-0033-1

  • Hypertrophy of the Heart

    Circulation · 2004 · https://doi.org/10.1161/01.cir.0000120390.68287.bb

  • Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress

    Nature Medicine · 2004 · 10.1038/nm1132

  • Cardiac Hypertrophy: The Good, the Bad, and the Ugly

    Annual Review of Physiology · 2003 · https://doi.org/10.1146/annurev.physiol.65.092101.142243

  • Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo

    Proceedings of the National Academy of Sciences · 2002 · 10.1073/pnas.231619298

  • Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy

    The EMBO Journal · 2001 · 10.1093/emboj/20.11.2757

  • Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A

    Circulation Research · 2001 · 10.1161/hh2301.100003

  • CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo

    Journal of Clinical Investigation · 2000 · 10.1172/jci8551

  • Calsarcins, a novel family of sarcomeric calcineurin-binding proteins

    Proceedings of the National Academy of Sciences · 2000 · 10.1073/pnas.260501097

  • Decoding calcium signals involved in cardiac growth and function

    Nature Medicine · 2000 · 10.1038/81321

  • Independent Signals Control Expression of the Calcineurin Inhibitory Proteins MCIP1 and MCIP2 in Striated Muscles

    Circulation Research · 2000 · 10.1161/01.res.87.12.e61

Current projects

    No projects listed.